These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15277228)

  • 1. Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.
    Yee KO; Streit M; Hawighorst T; Detmar M; Lawler J
    Am J Pathol; 2004 Aug; 165(2):541-52. PubMed ID: 15277228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
    Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
    Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
    Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
    Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
    Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
    J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Application of TGF-β-Activating Peptide, KRFK, Prevents Inflammatory Manifestations in the TSP-1-Deficient Mouse Model of Chronic Ocular Inflammation.
    Soriano-Romaní L; Contreras-Ruiz L; López-García A; Diebold Y; Masli S
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism.
    Yee KO; Connolly CM; Pines M; Lawler J
    Cancer Biol Ther; 2006 Feb; 5(2):218-24. PubMed ID: 16418571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model.
    Kuroki H; Hayashi H; Nakagawa S; Sakamoto K; Higashi T; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
    Br J Surg; 2015 Jun; 102(7):813-25. PubMed ID: 25866938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex.
    Young GD; Murphy-Ullrich JE
    J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.
    Streit M; Riccardi L; Velasco P; Brown LF; Hawighorst T; Bornstein P; Detmar M
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14888-93. PubMed ID: 10611308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.
    Lawler J
    J Cell Mol Med; 2002; 6(1):1-12. PubMed ID: 12003665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.
    Streit M; Velasco P; Brown LF; Skobe M; Richard L; Riccardi L; Lawler J; Detmar M
    Am J Pathol; 1999 Aug; 155(2):441-52. PubMed ID: 10433937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
    Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
    J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
    Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
    Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
    Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
    J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.
    Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD
    J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
    Aghi M; Rabkin SD; Martuza RL
    Cancer Res; 2007 Jan; 67(2):440-4. PubMed ID: 17234749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.
    Breitkopf K; Sawitza I; Westhoff JH; Wickert L; Dooley S; Gressner AM
    Gut; 2005 May; 54(5):673-81. PubMed ID: 15831915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
    Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.